Lubracane Gel
NDC Package 72235-5838-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Lubracane gel is a human otc drug administered via topical route. This formulation utilizes a gel delivery system. Marketed by Ozeion Llc, this product is identified by NDC 72235-5838 and is authorized under FDA application M341.

Identification & Billing

NDC Package Code
72235-5838-1
Package Description
118.3 mL in 1 JAR
Product Code
11-Digit Billing Format
72235583801

Clinical Specifications

Proprietary Name
Lubracane
Non-Proprietary Name
Lubracane
Substance Name
Menthol
Dosage Form
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)

Regulatory & Marketing

Labeler Name
Ozeion Llc
Product Type
Human Otc Drug
FDA Application #
M341
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-15-2018
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72235-5838-1 identifies a specific commercial package of 118.3 ml in 1 jar of Lubracane, a human over the counter drug labeled by Ozeion Llc. This gel is formulated for topical use and contains menthol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ozeion Llc on January 15, 2018. The current certification is valid through December 31, 2027.

How is this Ozeion Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72235583801. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
72235-5838-1
11-Digit CMS (5-4-2)
72235-5838-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.